Registration
Life Science Technology User Group
Join the Life Science Technology User Group for our “AI’nt this off the Chain?: AI and Block Chain in Life Sciences” event on September 11th from 5:00PM - 8:00 PM. We'll have a thought-provoking, informative and interactive session followed by a reception.
Agenda:
5:00 PM - 5:15 PM Check-in, Networking, Refreshments
5:15 PM - 5:45 PM “The Promise and the Myth of AI in Transforming Biopharma” with John Veytsman, Sr. Business Analyst, Biogen
5:45 PM - 6:00 PM Break
6:00 PM - 6:45 PM “AI and Blockchain in Biotech: Promise, Hype, and Challenges” with Poorya Hosseini, Associate, Flagship Pioneering
6:45 PM - 8:00 PM Reception
More about our speakers:
Poorya Hosseini, Ph.D., Associate, Flagship Pioneering
Poorya is an associate at Flagship Pioneering, working as part of a team of entrepreneurial scientists to conceive, create, resource and develop the next generation of Flagship’s first-in-category ventures. He is a founding member of VL49 Inc. (stealth mode) that aims to leverage cutting-edge computational tools in combination with biological omics to develop pioneering therapeutic solutions for cancer, immune, and inflammatory diseases.
Prior to joining the firm, Poorya completed his doctoral studies at the Massachusetts Institute of Technology (MIT). Poorya’s thesis work at MIT focused on the development of advanced label-free imaging techniques for studying biophysical properties of cells and tissues. Poorya has received several awards for his academic work, including the Edison Award for Impactful Research at MIT and the Iranian-American Medical Association’s Young Investigator Award for his work on anemic disorders. In addition to his scientific and entrepreneurial focus, Poorya is deeply interested in political science broadly, international relations, playing all sort of sports and fishing!
John Veytsman, Sr. Business Analyst, Biogen
John Veytsman is a Sr. Business Analyst within Biogen's R&D Information Technology group. He has a breadth of experience working across different functional domains ranging from Commercial to R&D and now in clinical devices / digital biomarkers. He has been a key advocate for artificial intelligence approaches to solving strategic problems across Biogen. He has played an instrumental role in the conceptualization and implementation of AI based solutions, ranging from target ID and validation initiatives in early discovery research to collaboration initiatives company-wide.
Event Details:
When:
From
- Tuesday, September 11, 2018
5:00 PM, EDT
To
- Tuesday, September 11, 2018 8:00 PM, EDT
Where:
Venture Cafe Kendall
1 Broadway, 14 Floor
Cambridge, MA 02142
Dell | One Dell Way | Round Rock, TX 78682 | www.dell.com
This email is an advertisement or solicitation. If you do not wish to receive email marketing from Dell, please Unsubscribe at Dell's Subscription Center. Dell respects your privacy. Please visit our privacy policy for more information.
Notice to public employees: At this event, items will be provided at no cost to attendees. The approximate fair market value of this event is $45. If, under applicable laws or the policies of your employer, you cannot attend this Event or any of the activities being paid for in connection with it, please do not do so. By registering for or attending this Event you certify that (1) to the best of your knowledge, you are not currently part of a bid evaluation team with respect to an opportunity to which Dell is a party; (2) you understand you are under no obligation to confer any business advantage on Dell; (3) you are allowed to attend under the laws and policies applicable to you; and (4) you will make payment to the vendor for the items listed as required by law. For more information or details, please contact For additional questions please contact brian.droney@dell.com